Cargando…

Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most prevalent cancer worldwide. Early detection of HCC is crucial to improve prognosis and survival. Nearly 30 % of HCC patients present with normal serum alpha fetoprotein (AFP), which highlights the need for new biomarkers for HCC. Annexin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saad, Zienab M, Fouad, Yasser, Ali, Lamia H, Hassanin, Taha M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779427/ https://www.ncbi.nlm.nih.gov/pubmed/32986366 http://dx.doi.org/10.31557/APJCP.2020.21.9.2661

Ejemplares similares

Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
por: Shaker, Mohamed K, et al.
Publicado: (2017)

Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone
por: Hassanin, Taha M, et al.
Publicado: (2021)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
por: Choi, Chel Hun, et al.
Publicado: (2016)

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma
por: Sun, Yulin, et al.
Publicado: (2013)

Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma
por: Ali, Lamia H, et al.
Publicado: (2019)

Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
por: Omar, Mona A., et al.
Publicado: (2023)

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
por: El Sagheer, Ghada M, et al.
Publicado: (2018)

Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma
por: Deng, Lu, et al.
Publicado: (2015)

Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma
por: Song, Ting, et al.
Publicado: (2021)

Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis
por: Herrera-López, Ema Elvira, et al.
Publicado: (2023)

Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
por: Qiu, Li-Wei, et al.
Publicado: (2020)

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013)

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
por: Chen, Hongda, et al.
Publicado: (2018)

Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
por: Ye, Liangtao, et al.
Publicado: (2020)

An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma
por: Abu El Makarem, Mona
Publicado: (2012)

Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma
por: Zhang, Xialu, et al.
Publicado: (2023)

Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
por: Takaya, Hiroaki, et al.
Publicado: (2019)

Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
por: Kohansal-Nodehi, Mahdokht, et al.
Publicado: (2023)

Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells
por: Wang, Ruo-Chiau, et al.
Publicado: (2015)

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
por: Itoh, S., et al.
Publicado: (2019)

Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
por: Ali, Omaima Mohamed, et al.
Publicado: (2020)

Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2022)

Identification of potential biomarkers for diagnosis of hepatocellular carcinoma
por: Liang, Xing-Hua, et al.
Publicado: (2022)

Advances in the early diagnosis of hepatocellular carcinoma
por: Wang, Weiyi, et al.
Publicado: (2020)

Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma
por: Wang, Yu, et al.
Publicado: (2018)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

Clinical Significance of Annexin A1 Expression in Breast Cancer
por: Yom, Cha Kyong, et al.
Publicado: (2011)

Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients
por: Ibrahim, Hassnaa M., et al.
Publicado: (2021)

Clinical Significance of Annexin A2 Expression in Breast Cancer Patients
por: Gibbs, Lee D., et al.
Publicado: (2020)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention
por: Ezzat, Wafaa M, et al.
Publicado: (2016)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Expression and clinical significance of Nectin-4 in hepatocellular carcinoma
por: Ma, Jie, et al.
Publicado: (2016)

Prognostic significance of XRCC4 expression in hepatocellular carcinoma
por: Lu, Jun, et al.
Publicado: (2017)

Clinical significance of CMTM4 expression in hepatocellular carcinoma
por: Bei, Chunhua, et al.
Publicado: (2017)

The expression and clinical significance of TPM4 in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021)

Clinical Significance of TUBGCP4 Expression in Hepatocellular Carcinoma
por: Zheng, Chuanjun, et al.
Publicado: (2022)

Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma
por: Salem, Mona, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d5dapnr3sfnfebmr1iogptabha